The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Polymer Factory
Stockholm, Sweden
A
1-10 Employees
2006
Key takeaway
Polymer Factory is a leading provider of advanced dendritic materials, including biocompatible bis-MPA dendrimers and dendrons, which are relevant for research purposes.
Reference
Core business
Polymer Factory | Sweden | Dendrimers & Calibration Standards
Polymer Factory Sweden AB is the only company who provides highly specific and complex dendritic materials such as dendrimers, multifunctional PEGs and hyperbranched polymers, as well as MALDI-ToF calibration standards
Dendris
Labège, France
A
1-10 Employees
2009
Key takeaway
Dendris has patented a surface chemistry process for dendrimers, highlighting their innovative approach to molecular diagnosis. Their DendrisKIT products facilitate the rapid identification of various pathogens, showcasing the company's commitment to fast and accurate diagnostic solutions.
Reference
Core business
Dendris | Next Generation Diagnosis
Meros Polymers
Edmonton, Canada
A
1-10 Employees
2009
Key takeaway
Meros has developed innovative delivery systems, including ExCell™ and PolyGel™, which are designed to enhance the targeting of small molecule drugs and RNAi to cancer cells in vivo. The company offers research-grade polymers and expertise in custom formulation to optimize delivery vehicles for various compounds.
Reference
Product
Products | Meros Polymers
Meros can provide you with research grade polymers for in-house testing. We offer PolyGel as well as an extensive catalog of ExCell variations available for purchase. We can also create custom polymers for your compounds.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Broadpharm
San Diego, United States
B
1-10 Employees
2009
Key takeaway
The company, BroadPharm®, specializes in manufacturing high purity PEG linkers and advanced bio-labeling reagents, which may be relevant for applications involving dendrimers in the pharmaceutical and biotech industries. They also offer custom synthesis and technical support to optimize the use of their products.
Reference
Product
PEG Linker, Click Chemistry Tools, ADC linker, PEG lipid, Fluorescent dye | BroadPharm
Designer Molecules Inc.
San Diego, United States
B
1-10 Employees
2001
Key takeaway
The company, DMI, specializes in creating functionalized monomers and oligomers that can be integrated into various applications, including adhesives and coatings. They develop new molecules and offer a range of specialty products that may be relevant to advancements in dendrimer technology.
Reference
Core business
Designer Molecules Inc.
Superior Silica
Chandler, United States
B
1-10 Employees
2015
Key takeaway
The company, Superior Silica, highlights its proprietary technology that allows for the large-scale production of monodisperse silica nanoparticles, emphasizing their uniformity and ability to target specific sizes.
Reference
Core business
Monodisperse Spherical Silica Nanoparticle Supplier - Superior Silica
Superior Silica LLC - Our uniformity, scalability, and size targeting of silica nanoparticles help us stand out above the rest. Click to learn more.
POLYTHERAGENE
Évry, France
A
1-10 Employees
-
Key takeaway
Polytheragene specializes in the synthesis of cationic polymers, particularly those with histidine, aimed at enhancing non-viral gene transfer techniques. They develop and commercialize polymer-based technologies that improve DNA transfection efficiency while reducing toxicity, addressing key challenges in gene therapy.
Reference
Core business
Company – Polytheragene
GLYCON Biochemicals Entwicklungs-Produktions- und Vertriebs GmbH
Luckenwalde, Germany
A
1-10 Employees
-
Key takeaway
Glycon is introducing new reagents based on DIBMA (diisobutylene/maleic acid copolymer) that facilitate the gentle extraction of membrane proteins to create lipid-bilayer nanodiscs, enhancing the efficiency of protein extraction. Their innovative glycopolymer, Glyco-DIBMA, produces smaller and more uniform nanodiscs.
Reference
Core business
Glycon - Biochemicals GmbH
GLYCON Biochemicals GmbH
Luckenwalde, Germany
A
1-10 Employees
-
Key takeaway
Glycon is introducing new reagents based on DIBMA (diisobutylene/maleic acid copolymer) that facilitate the gentle extraction of membrane proteins to create lipid-bilayer nanodiscs, enhancing their existing product line.
Reference
Core business
Glycon - Biochemicals GmbH
CELARES GmbH
Berlin, Germany
A
11-50 Employees
2003
Key takeaway
Biosynth GmbH specializes in the synthesis of polymers for drug delivery, including the preparation of functionalized PEGs. Their expertise in bioconjugation and innovative technologies positions them as a leader in developing advanced drug formulation strategies.
Reference
Service
Synthesis services – Celares GmbH
Our synthetic services are focused on the preparation of polymers relevant to pharmaceutical applications, such as functionalized PEGs and others.
Technologies which have been searched by others and may be interesting for you:
Dendrimers are highly branched, tree-like macromolecules characterized by their unique structure and nanometer size. These molecules consist of a central core, branching units, and terminal functional groups, which allow for precise control over their size, shape, and surface properties. Their architecture enables dendrimers to encapsulate drugs, deliver genes, or serve as catalysts in various chemical reactions. The versatility of dendrimers makes them valuable in fields such as drug delivery, diagnostics, and materials science. Their ability to interact with biological systems at the nanoscale facilitates targeted therapy and improved drug solubility, enhancing therapeutic efficiency.
Dendrimers are highly branched, tree-like polymers that offer a unique architecture for drug delivery applications. Their nanoscale size and functional surface groups enable them to encapsulate drugs effectively, enhancing solubility and stability. By modifying these surface groups, dendrimers can be engineered to improve targeting capabilities, allowing for the selective delivery of therapeutic agents to specific cells or tissues, such as cancerous cells. Moreover, dendrimers can facilitate controlled release of the drug, ensuring a sustained therapeutic effect while minimizing side effects. This versatility makes them an attractive option for various pharmaceutical applications, including gene therapy and vaccine development, where precise delivery mechanisms are crucial for efficacy.
1. Enhanced Drug Delivery
Dendrimers are highly branched, tree-like structures that provide a unique platform for drug delivery systems. Their nanoscale size allows for improved penetration and distribution within biological systems, facilitating targeted therapy. This precision minimizes side effects and enhances therapeutic efficacy.
2. Versatile Functionalization
The surface of dendrimers can be easily modified with various functional groups, enabling the attachment of multiple therapeutic agents or imaging probes. This versatility allows for the creation of multifunctional nanocarriers, which can combine diagnostic and therapeutic capabilities, thus advancing personalized medicine and targeted treatments.
Dendrimers are synthesized through a method known as iterative growth. This process involves a series of chemical reactions that build the dendrimer's branched structure layer by layer. Typically, a central core initiates the synthesis, followed by the attachment of dendritic units or functional groups. The most common techniques include the divergent approach, where new layers are added outward from the core, and the convergent approach, which involves constructing dendritic arms separately before combining them with a core. Each method allows for precise control over the size and function of the dendrimer, making them versatile for applications in drug delivery, gene therapy, and materials science.
Dendrimers are highly branched, synthetic macromolecules that have unique properties making them valuable in various medical applications. They are utilized in drug delivery systems, enabling targeted therapy by improving the solubility and bioavailability of therapeutic agents. This targeted approach reduces side effects and enhances the efficacy of drugs, particularly in cancer treatment. Additionally, dendrimers serve as imaging agents in diagnostics, allowing for enhanced contrast in medical imaging techniques. Their multifunctional nature also supports the development of vaccines and gene delivery systems, providing a platform for the transport of nucleic acids into cells. Overall, dendrimers represent a versatile tool in advancing medical therapies and technologies.
Some interesting numbers and facts about your company results for Dendrimer
Country with most fitting companies | United States |
Amount of fitting manufacturers | 9228 |
Amount of suitable service providers | 5792 |
Average amount of employees | 1-10 |
Oldest suiting company | 2001 |
Youngest suiting company | 2015 |
20%
40%
60%
80%
Some interesting questions that has been asked about the results you have just received for Dendrimer
What are related technologies to Dendrimer?
Based on our calculations related technologies to Dendrimer are Glass, Superconductors, High-Performance Materials, Raw Materials, Phase Change Materials
Which industries are mostly working on Dendrimer?
The most represented industries which are working in Dendrimer are Biotechnology, Other, Chemicals, Pharmaceuticals, Medical
How does ensun find these Dendrimer Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.